Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
31
Frequently Asked Questions
What is Market Cap of Nephros Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nephros Inc market cap is $45.16M.
What is the 52-week high for Nephros Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nephros Inc 52 week high is $5.00 as of September 15, 2025.
What is the 52-week low for Nephros Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nephros Inc 52 week low is $1.36 as of September 15, 2025.
What is Nephros Inc stock price today?
Nephros Inc stock price today is $4.66.
What was Nephros Inc stock price yesterday?
Nephros Inc stock price yesterday was $4.26.
What is the PE ratio of Nephros Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nephros Inc’s P/E ratio is 34.11.
What is the Price-to-Book ratio of Nephros Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nephros Inc P/B ratio is 4.7045.
What is the 50-day moving average of Nephros Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nephros Inc 50-day moving average is $3.83.